Increases risk of other respiratory infections [26] and exacerbates conditions such as asthma. Increase risk of serious complications from COVID-19 [28] |
|
Reduces efficacy of many psychiatry medications [29] |
Poor mental health symptom control
Need for higher doses of medications giving more side effects
Need for more blood tests for measuring drug levels e.g.: Clozapine
|
Contributing and worsening factor for mental illness [29]. Increased likelihood of smoking during COVID-19 due to lockdown and related stress. |
|
Increase long term risk of cardiovascular and respiratory diseases, and cancers [3]. |
|
Increases risk of ex-smokers relapsing back to smoking due to the stress [23] and peer pressure in inpatient settings as a result of relaxed smokefree policies during COVID-19. |
|